About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, July 20th, 2016

The QualityStocks
Daily Stock List


1pm Industries, Inc. (OPMZ)

Wall Street Mover, SMS Penny Picks, elitetotc.com, Jet-Life Penny Stocks, Value Penny Stocks, Equity Observer, Broad Street, OTCBB Journal, StocksImpossible, StockHideout, Wall Street Beauties, WINNINGOTC, SmallCapAllStars, TryBestPennyStocks.biz, SmallCapVoice, and Cannabis Financial Network News reported on 1pm Industries, Inc. (OPMZ), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

1pm Industries, Inc.’s business centers on the sale and distribution of medical marijuana under the award-winning brand, Von Baron Farms. The Company launched www.vonbaronlabs.com, which sells its complete CBD line.  Products can be purchased by anyone and shipped anywhere in the United States. 1pm Industries’ lists on the OTC Markets’ OTCQB. The Company is based in Beverly Hills, California.

Von Baron Labs’ products are extracted from industrial hemp plants. They contain no THC, which is the psychoactive constituent in marijuana. The CBD hemp oil extracts in any form are legal in every State in the U.S.

1pm Industries’ Nano-CBD are ion-sized nutrients of CBD encased with water molecules. Because of their extremely small size, nano-particles ingested in food and water are basically different. In addition, they can move throughout the body in advanced ways via cells' membranes. Typically, only 7-10 percent of CBD ingested is absorbed and used by the body.  However, nanotechnology enables the body to absorb up to 95 percent of the CBD.

1pm Industries’ CBD product line includes 50 mg and 100mg CBD versions of its multiple award winning Cookie Spread; CBD Shots; BuzzKill, which contains 50Mg of CBD; Shake and Pour Pancake and Waffle Mix, as well as CBD Gummie. 

1pm Industries has launched its CBD Shot and E-Commerce Site for its Nano-Cannabidiol (Nano-CBD) product line. Its CBD shot is a 1.9 ounce CBD shot with the equivalent of 100mg of CBD. The Company states that its CBD Shot has some anti-pain, anti-inflammatory, as well as anti-anxiety benefits. Yet, this is without any kind of high. The CBD Shot doesn't put a person to sleep. It calms a person down and it enables one to deal with things.

Recently, 1pm Industries announced that it expanded its award winning Von Baron Farms products to the Southern California region.  It commenced delivering product to dispensaries in Southern California on June 27, 2016. It started selling its medical marijuana products to dispensaries in California in January of this year. The Company is now selling its products in around 40 dispensaries. At present, 1pm Industries is concentrating on dispensaries in Northern California and expanding to Southern California. Further, it has started its final phase of development on its THC infused coffee creamers. It expects to launch the product in September 2016. Therefore, this will expand its product line to Cookie Spread, CBD Shot, BuzzKill, THC Shot, Breaking Batter Shake & Pour and Infused Coffee Creamer.

1pm Industries, Inc. (OPMZ), closed Wednesday's trading session at $0.0398, down 0.25%, on 55,900 volume with 7 trades. The average volume for the last 60 days is 130,453 and the stock's 52-week low/high is $0.0338/$0.65.

MyDx, Inc. (MYDX)

CFN Media Group, Cannabis Financial Network News, Cabot Wealth, SmallCap Network and Greenbackers reported on MyDx, Inc. (MYDX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

MyDx, Inc. is a science and technology company whose shares trade on the OTC Bulletin Board. It develops and commercializes technology and devices to accurately measure chemicals of interest in solid, liquid, or gas samples. MyDx is developing a device that directly measures what people eat, drink, and inhale. It has the world's first consumer handheld chemical analyzer. This product analyzes foods, drinks, and air for chemicals of interest. On September 10, 2015, MyDx announced that it successfully transitioned from a research and development (R&D) to a revenue generating business. MyDx has its corporate head office in San Diego, California.

MyDx’s device enables one to place a sample in a test chamber and see a total chemical analysis in a smartphone application (app). The Company offers MyDx, also called My Diagnostic. This is a portable analyzer that provides real-time chemical analysis that fits in the palm of users’ hands. Additionally, MyDx offers MyDx App, which provides the user with more information to understand the chemicals found by the MyDx Analyzer.

MyDx is the first battery operated, handheld, electronic analyzer for consumers. MyDx utilizes nanotechnology to accurately measure chemicals of interest and has multiple sensors undergoing development in its lab that are compatible with the MyDx App. MyDx™ is a portable analyzer that will detect the chemicals one cannot see. A user connects the MyDx™ to their iOS, Android or Windows device. They subsequently place a sample in the chamber and push measure for an in-depth analysis of their sample within seconds.

Last month, MyDx announced it signed an agreement with Arrow Electronics to scale its supply chain and contract manufacturing capabilities for its MyDx product line. With this agreement, Arrow Electronics will provide end-to-end supply chain management and contract manufacturing support, technical support and a credit facility for the MyDx chemical analyzer product line. Arrow Electronics is a Fortune 150 company. It is an international provider of products, services and solutions to industrial and commercial users of electronic components and enterprise computing solutions. Arrow Electronics is headquartered in Englewood, Colorado.

Last week, MyDx announced it expects to surpass its earlier reported revenue guidance for its Q2 ending June 30, 2016.  The revenue growth is being driven by its recent introduction of its patented MyDx™ (My Diagnostic) product line. The Company expects to report that revenues grew to roughly $282,000 for its Q2 ended June 30, 2016. This represents a sequential increase of more than 75 percent versus the $161,000 it posted for its Q1 ended March 31, 2016. MyDx earlier provided revenue goals of around $225,000 during the LD Micro Investor Conference held on June 8, 2016.

MyDx, Inc. (MYDX), closed Wednesday's trading session at $0.1647, down 3.12%, on 131,062 volume with 13 trades. The average volume for the last 60 days is 47,080 and the stock's 52-week low/high is $0.10/$1.94.

Pressure BioSciences, Inc. (PBIO)

Stock News Now, DreamTeamNetwork, SeeThruEquity Research, SmallCapFinancialWire, Marketbeat.com, and SECFilings.com News reported on Pressure BioSciences, Inc. (PBIO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pressure BioSciences, Inc. focuses on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology (PCT).  PCT is a patented, enabling technology platform with numerous applications in the life sciences sample preparation market. PCT utilizes cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. OTCQB-listed, Pressure BioSciences is based in South Easton, Massachusetts.

Pressure BioSciences is directing its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications. The Company’s principal application development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas.

To date (as of July 13, 2016), Pressure BioSciences has installed more than 275 PCT systems in approximately 160 sites globally. The PCT Sample Preparation System (PCT SPS) allows for the safe, fast, and reproducible extraction of DNA, RNA, small molecules, and proteins from a wide assortment of cells and tissues, especially those considered ‘hard-to-lyse’. The PCT SPS uses a Barocycler NEP3220, in tandem with PULSE™ Tubes.

The Company’s products include Barocycler Instruments, Shredders, PULSE Tubes (PT), PCT MicroTubes and PCT MicroCaps, PCT µPestle System, The Barozyme™ HT48, and also Kits & Reagents. In addition, Pressure BioSciences is an authorized distributor of Constant Systems Ltd. products in the United States, Mexico, and Canada.

The Barozyme HT48 is a first-in-class, high throughput, PCT-based instrument. It can process up to 48 samples at the same time using Pressure BioSciences’ proprietary BaroFlex 8-well, single-use processing strips. Jointly, the new Barozyme HT48 instrument and BaroFlex 8-well processing strips make up the Barozyme HT48 High-throughput System (the Barozyme HT48 System).

Last week, Pressure BioSciences announced the unveiling of the newest addition to its product line based on its PCT platform, the Barocycler 2320EXTREME (2320EXT).  The product unveiling occurred during the recent annual conference of the American Society for Mass Spectrometry (ASMS) in San Antonio, Texas.  Additionally, the Company announced that scientists from six separate research groups made presentations on Pressure BioSciences’ PCT-based product line at the same international conference.

Results given indicated that Pressure BioSciences’ PCT-based instruments and consumables, when used in the preparation of samples for mass spectrometric analysis, resulted in critically enabling qualitative and quantitative improvements and/or improved time or cost efficiency.

Pressure BioSciences, Inc. (PBIO), closed Wednesday's trading session at $0.438, up 1.86%, on 20,298 volume with 11 trades. The average volume for the last 60 days is 70,847 and the stock's 52-week low/high is $0.20/$0.58.

Soligenix, Inc. (SNGX)

Streetwise Reports, StockOodles, PennyStocks24, Stockgoodies, OTC Markets Group, Pennybuster, and InvestorPlace reported on Soligenix, Inc. (SNGX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Soligenix, Inc. is a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology, and biodefense. Its proprietary vaccine thermostabilization technology is ThermoVax™.  Soligenix’s areas of concentration include a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need. This includes cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host disease (GVHD). Soligenix is headquartered in Princeton, New Jersey.
The Company’s second area of focus is a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis. Soligenix is developing proprietary formulations of oral BDP (beclomethasone 17,21-dipropionate) for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation. This includes pediatric Crohn's disease (SGX203) and acute radiation enteritis (SGX201).

In addition, Soligenix is advancing its novel innate defense regulator (IDR) technology SGX942 for the treatment of oral mucositis and SGX301, its novel first-in-class photodynamic technology utilizing synthetic hypericin with safe visible light, for the treatment of cutaneous T-cell lymphoma. Its biodefense products undergoing development include a recombinant subunit vaccine named RiVax™. The design of it is to protect against the lethal effects of exposure to ricin toxin. RiVax™ has been granted orphan drug designation by the Food and Drug Administration (FDA) for the prevention of ricin intoxication.

The Soligenix BioDefense business segment also includes active development programs for OrbeShield™, its GI acute radiation syndrome therapeutic candidate. This business segment is also developing SGX101 and SGX943, the Company’s melioidosis therapeutic candidates. SGX943 is a therapeutic using novel Innate Defense Regulator or IDR (dusquetide) that has demonstrated significant survival results in a mouse model of melioidosis.

This week, Soligenix announced positive preliminary proof-of-concept results from its collaboration with Axel Lehrer, PhD of the Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine (JABSOM), University of Hawaii at Mānoa (UH Mānoa) and Hawaii Biotech, Inc. (HBI) to develop a heat stable subunit Ebola vaccine.  Thermostabilization formulation studies were conducted with Theodore Randolph, PhD at the University of Colorado Boulder. These studies identified a formulation, which enhances the physical stability of the protein and may be dose sparing, allowing immunization to potentially be attained with fewer vaccinations.

Soligenix, Inc. (SNGX), closed Wednesday's trading session at $0.64, down 1.23%, on 43,565 volume with 28 trades. The average volume for the last 60 days is 80,890 and the stock's 52-week low/high is $0.4401/$2.09.

Soupman, Inc. (SOUP)

DreamTeamNetwork, The Wall Street Transcript, TopPennyStockMovers, Stock Guru, The Street, FeedBlitz, Street Beat, and Pumps and Dumps reported on Soupman, Inc. (SOUP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed Soupman, Inc. sells soup across the United States in Tetra Pak cartons. It sells in grocery stores and also in the Company’s franchise restaurants, soupmobiles and foodservices. The Original SoupMan® opened its doors in 1984 at 55th Street & 8th Avenue in Manhattan. Soupman has its corporate headquarters in Staten Island, New York.

In 2016, Soupman has added two new flavors to its lineup. These are Shrimp Bisque and Turkey Stew. This brings to eight the number of varieties of Soupman soup that are available in supermarkets across the nation. The other varieties available in Tetra Pak cartons include Lobster Bisque, Gluten-Free Lentil, Jambalaya, Crab & Corn Chowder, Chicken Gumbo, and Chicken Noodle.

All Soupman soups are packaged in environmentally friendly, "green" Tetra Pak cartons. These cartons are shelf stable. The design of them is to keep product flavor first-rate without preservatives.

In addition, Soupman soups are available in the soup aisle of fine grocers and supermarkets nationally. These include Kroger, Safeway, Publix, HEB, Shoprite, Wegmans, as well as other retailers.

Recently, Soupman announced that it shipped its first deliveries of six varieties of its Tetra Pak carton soups to all Heinen's stores. The Company also shipped product to all 700 Bi-Lo and Winn Dixie stores at the end of April 2016.

Soupman’s Revenues for this past Q2 surpassed previous year sales for the same quarter by 58 percent. Building on increased revenues over the past two quarters, Soupman projects 2016 revenues to significantly surpass 2015 revenues.

Last month, Soupman announced that it shipped its initial truckloads of soup to 155 Shaw's Supermarket stores in the New England region. The Soupman will make personal appearances at the Shaw's stores this Fall and Winter signing autographs and sampling the Soupman soups to guests.

Mr. Jamieson A. Karson, Chief Executive Officer of Soupman, said, “Our expanding distribution including Shaw's, Bi-Lo, Winn Dixie, Heinen's, and others this Spring should help us achieve our internal sales projections for the balance of the year and beyond."

Soupman, Inc. (SOUP), closed Wednesday's trading session at $0.03, up 15.38%, on 53,240 volume with 7 trades. The average volume for the last 60 days is 184,719 and the stock's 52-week low/high is $0.0202/$0.17.


The QualityStocks
Company Corner


Monaker Group, Inc. (MKGI)

The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.70, up 5.88%, on 10,342 volume with 15 trades. The stock’s average daily volume over the past 60 days is 6,861, and its 52-week low/high is $1.10/$5.95.

Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.

NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.

Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.

Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.

In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.

With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.

Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer

Monaker Group, Inc. Company Blog

Monaker Group, Inc. News:

Monaker Group Files Annual Report on Form 10K for Fiscal 2016

Monaker Group Shareholder Update

MissionIR Exclusive Audio Interview With Monaker Group, Inc. (MKGI) Chief Executive Officer

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.005, up 2.04%, on 780,227 volume with 22 trades. The stock’s average daily volume over the past 60 days is 2,465,357 and its 52-week low/high is $0.0046/$0.212.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Announces Plan to Restructure and Consolidate Outstanding Debt

Dominovas Energy Welcomes Project Finance Team

Dominovas Energy Launches New Hydropower Division – Currentergy

Agora Holdings, Inc. (AGHI)

The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.114175, up 3.33%, on 22,800 volume with 4 trades. The stock’s average daily volume over the past 60 days is 67,910, and its 52-week low/high is $0.03/$0.7999.

Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.

Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.

For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.

Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.

Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer

Agora Holdings, Inc. Company Blog

Agora Holdings, Inc. News:

Agora Holdings Inc. Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level

Agora Holdings, Inc. Updates Shareholders on FRAME Technology, Accounting Audit

Agora Holdings Inc. Signs Engagement Letter With Auditing Firm, BF Borgers CPA PC

OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.91, up 1.11%, on 3,680 volume with 3 trades. The stock’s average daily volume over the past 60 days is 4,973, and its 52-week low/high is $0.60/$1.06.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

OurPet's Company Now Licensing Polymer Bonded Pet Bowl Patent

OurPet's Company Sponsors 65th Annual BetterInvesting National Convention

OurPet’s Company Reports Record 2016 First Quarter Results

Star Mountain Resources, Inc. (SMRS)

The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $0.39, up 5.41%, on 2,500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,217, and its 52-week low/high is $0.30/$1.25.

Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.

Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.

The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.

Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer

Star Mountain Resources, Inc. Company Blog

Star Mountain Resources, Inc. News:

Star Mountain Resources Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust

Star Mountain Resources Receives Industry Guide 7 Mineral Reserves Report on Balmat Mine

Star Mountain Resources, Inc. Closes Acquisition of Balmat Zinc Mine in New York State


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



MarketClub Analysis




Profitable Trader Authority

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251